161 related articles for article (PubMed ID: 17412838)
1. Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase.
Hazra S; Batra RK; Tai HH; Sharma S; Cui X; Dubinett SM
Mol Pharmacol; 2007 Jun; 71(6):1715-20. PubMed ID: 17412838
[TBL] [Abstract][Full Text] [Related]
2. Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells.
Hazra S; Dubinett SM
Prostaglandins Leukot Essent Fatty Acids; 2007 Jul; 77(1):51-8. PubMed ID: 17697767
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone, a PPARγ agonist, suppresses CYP19 transcription: evidence for involvement of 15-hydroxyprostaglandin dehydrogenase and BRCA1.
Subbaramaiah K; Howe LR; Zhou XK; Yang P; Hudis CA; Kopelovich L; Dannenberg AJ
Cancer Prev Res (Phila); 2012 Oct; 5(10):1183-94. PubMed ID: 22787115
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of prostaglandin transport and metabolism augment protease-activated receptor-2-mediated increases in prostaglandin E2 levels and smooth muscle relaxation in mouse isolated trachea.
Henry PJ; D'Aprile A; Self G; Hong T; Mann TS
J Pharmacol Exp Ther; 2005 Sep; 314(3):995-1001. PubMed ID: 15937152
[TBL] [Abstract][Full Text] [Related]
5. Thiazolidinediones up-regulate insulin-like growth factor-1 receptor via a peroxisome proliferator-activated receptor gamma-independent pathway.
Higashi Y; Holder K; Delafontaine P
J Biol Chem; 2010 Nov; 285(47):36361-8. PubMed ID: 20843793
[TBL] [Abstract][Full Text] [Related]
6. IL-4 regulates COX-2 and PGE2 production in human non-small cell lung cancer.
Cui X; Yang SC; Sharma S; Heuze-Vourc'h N; Dubinett SM
Biochem Biophys Res Commun; 2006 May; 343(4):995-1001. PubMed ID: 16574063
[TBL] [Abstract][Full Text] [Related]
7. HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells.
Moore AE; Greenhough A; Roberts HR; Hicks DJ; Patsos HA; Williams AC; Paraskeva C
Carcinogenesis; 2009 Oct; 30(10):1796-804. PubMed ID: 19638428
[TBL] [Abstract][Full Text] [Related]
8. Microsomal prostaglandin E synthase-1 deficiency is associated with elevated peroxisome proliferator-activated receptor gamma: regulation by prostaglandin E2 via the phosphatidylinositol 3-kinase and Akt pathway.
Kapoor M; Kojima F; Qian M; Yang L; Crofford LJ
J Biol Chem; 2007 Feb; 282(8):5356-66. PubMed ID: 17186945
[TBL] [Abstract][Full Text] [Related]
9. NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer.
Ding Y; Tong M; Liu S; Moscow JA; Tai HH
Carcinogenesis; 2005 Jan; 26(1):65-72. PubMed ID: 15358636
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone inhibits androgen production in NCI-H295R cells by regulating gene expression of CYP17 and HSD3B2.
Kempná P; Hofer G; Mullis PE; Flück CE
Mol Pharmacol; 2007 Mar; 71(3):787-98. PubMed ID: 17138841
[TBL] [Abstract][Full Text] [Related]
11. PPARγ agonists target aromatase via both PGE2 and BRCA1.
Margalit O; Wang D; Dubois RN
Cancer Prev Res (Phila); 2012 Oct; 5(10):1169-72. PubMed ID: 23041473
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.
Mughal RS; Warburton P; O'Regan DJ; Ball SG; Turner NA; Porter KE
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):478-86. PubMed ID: 19673929
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-gamma inhibits transformed growth of non-small cell lung cancer cells through selective suppression of Snail.
Choudhary R; Li H; Winn RA; Sorenson AL; Weiser-Evans MC; Nemenoff RA
Neoplasia; 2010 Mar; 12(3):224-34. PubMed ID: 20234816
[TBL] [Abstract][Full Text] [Related]
14. Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E2.
Brecht K; Weigert A; Hu J; Popp R; Fisslthaler B; Korff T; Fleming I; Geisslinger G; Brüne B
FASEB J; 2011 Jul; 25(7):2408-17. PubMed ID: 21450910
[TBL] [Abstract][Full Text] [Related]
15. Antitumorigenic effects of peroxisome proliferator-activated receptor-gamma in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-kappaB.
Bren-Mattison Y; Meyer AM; Van Putten V; Li H; Kuhn K; Stearman R; Weiser-Evans M; Winn RA; Heasley LE; Nemenoff RA
Mol Pharmacol; 2008 Mar; 73(3):709-17. PubMed ID: 18055759
[TBL] [Abstract][Full Text] [Related]
16. Thiazolidinediones increase arachidonic acid release and subsequent prostanoid production in a peroxisome proliferator-activated receptor gamma-independent manner.
Tsukamoto H; Hishinuma T; Suzuki N; Tayama R; Hiratsuka M; Yoshihisa T; Mizugaki M; Goto J
Prostaglandins Other Lipid Mediat; 2004 Apr; 73(3-4):191-213. PubMed ID: 15287152
[TBL] [Abstract][Full Text] [Related]
17. β-catenin represses expression of the tumour suppressor 15-prostaglandin dehydrogenase in the normal intestinal epithelium and colorectal tumour cells.
Smartt HJ; Greenhough A; Ordóñez-Morán P; Talero E; Cherry CA; Wallam CA; Parry L; Al Kharusi M; Roberts HR; Mariadason JM; Clarke AR; Huelsken J; Williams AC; Paraskeva C
Gut; 2012 Sep; 61(9):1306-14. PubMed ID: 22082586
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by cyclooxygenase inhibitors and chemopreventive agents.
Cho H; Tai HH
Prostaglandins Leukot Essent Fatty Acids; 2002 Dec; 67(6):461-5. PubMed ID: 12468268
[TBL] [Abstract][Full Text] [Related]
19. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
Otani T; Yamaguchi K; Scherl E; Du B; Tai HH; Greifer M; Petrovic L; Daikoku T; Dey SK; Subbaramaiah K; Dannenberg AJ
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G361-8. PubMed ID: 16195422
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin catabolic enzymes as tumor suppressors.
Tai HH
Cancer Metastasis Rev; 2011 Dec; 30(3-4):409-17. PubMed ID: 22020925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]